Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-011728
Filing Date
2026-02-25
Accepted
2026-02-25 16:36:22
Documents
1
Period of Report
2026-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1772055379.html 4  
1 FORM 4 wk-form4_1772055379.xml 4 5755
  Complete submission text file 0001628280-26-011728.txt   7180
Mailing Address 6055 LUSK BLVD. SAN DIEGO CA 92121
Business Address 6055 LUSK BLVD. SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Issuer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD SAN DIEGO CA 92121
Business Address
Schilke Tobin (Reporting) CIK: 0001678984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38583 | Film No.: 26679442